COVID-19 infection in patients with malignant diseases

Dejan Đokanović; Zdenka  Gojković; Gordan  Nikić; Olja  Jović-Djokanović; Zoran  Mavija; Ivanka  Rakita; Saša  Jungić; Milka  Vještica; Jelena  Berendika; Tamara  Višekruna

doi:10.2298/VSP201016114G

Dejan Đokanović Oncology Clinic, University Clinical Centre of the Republic of Srpska
Zdenka Gojković Universitiy Clinical Center of the Republic of Srpska, Oncology Clinic, Banja Luka
Gordan Nikić Universitiy Clinical Center of the Republic of Srpska, Oncology Clinic, Banja Luka
Olja Jović-Djokanović Universitiy Clinical Center of the Republic of Srpska, Infectology Clinic, Banja Luka
Zoran Mavija Universitiy Clinical Center of the Republic of Srpska, Department of Gastroenterology and Hepatology, Banja Luka
Ivanka Rakita Universitiy Clinical Center of the Republic of Srpska, Oncology Clinic, Banja Luka
Saša Jungić Universitiy Clinical Center of the Republic of Srpska, Oncology Clinic, Banja Luka
Milka Vještica Universitiy Clinical Center of the Republic of Srpska, Oncology Clinic, Banja Luka
Jelena Berendika Universitiy Clinical Center of the Republic of Srpska, Oncology Clinic, Banja Luka
Tamara Višekruna Universitiy Clinical Center of the Republic of Srpska, Oncology Clinic, Banja Luka

DOI: https://doi.org/10.2298/VSP201016114G

References

http://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/. [cited 2020 January 12].

Tan W, Zhao X, Ma X, Wang W, Niu P, Gao GF, et al. A nov-el coronavirus genome identified in a cluster of pneumonia cases- Wuhan, China 2019−2020. China CDC Weekly 2020; 2(4): 61−2. Available from: http://weekly.chinacdc.cn/en/article/id/a3907201-f64f-4154-a19e-4253b453d10c.

Kamboj M, Sepkowitz KA. Nosocomial infections in patients with cancer. Lancet Oncol 2009; 10(6): 589−97.

Li JY, Duan XF, Wang LP, Xu YJ, Huang L, Zhang TF, et al. Selective depletion of regulatory T cell subsets by docetaxel treatment in patients with nonsmall cell lung cancer. J Im-munol Res 2014; 2014: 286170.

Longbottom ER, Torrance HD, Owen HC, Fragkou PC, Hinds CJ, Pearse RM, et al. Features of Postoperative Immune Suppres-sion Are Reversible With Interferon Gamma and Inde-pendent of Interleukin-6 Pathways. Ann Surg 2016; 264(2): 370−7.

Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020; 21(3): 335−7.

Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Char-acteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA 2020; 323(18): 1775−6.

Dingenmans AC, De Toma A, Viscardi G, Pancaldi V, Mazieres J, Trama A, et al. International registry on thoracic cancer patients with COVID-19 TERAVOLT. Milano: Fondazione IRCCS Istituto Nazionale Tumori; 2020.

Barlesi F, Foulon S, Bayle A, Gachot B, Pommeret F, Willekens C, et al. Outcome of cancer patients infected with COVID-19, including toxicity of cancer treatments. Proceedings: AACR Annual Meeting 2020; Philadelphia, PA; 2020 April 27−28; and 2020 June 22−24. Abstract CT403. Am Assoc Cancer Res 2020; 80 (16 Suppl): 10.1158/1538-7445.AM2020-CT403.